OHR PHARMACEUTICAL INC - COM NEW (OHRP)

CUSIP: 67778H200

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM NEW
Total 13F shares
5,149,122
Share change
-585,416
Total reported value
$1,129,000
Put/Call ratio
33%
Price per share
$0.22
Number of holders
29
Value change
-$1,455,007
Number of buys
14
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 67778H200?
CUSIP 67778H200 identifies OHRP - OHR PHARMACEUTICAL INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OHR PHARMACEUTICAL INC - COM NEW (OHRP) as of Q1 2018

As of 31 Mar 2018, OHR PHARMACEUTICAL INC - COM NEW (OHRP) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,149,122 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GARRISON BRADFORD & ASSOCIATES INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Virtu Financial LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, WEDBUSH SECURITIES INC, and Creative Planning. This page lists 29 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.